ILA 170.4
(3.09%)
Breakdown | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Revenue | -3.45 Million | -7.14 Million | 5.03 Million | - |
Cost of Revenue | - | - | - | - |
Gross Profit | -3.45 Million | -7.14 Million | 5.03 Million | - |
Operating Expenses | 855 Thousand | 552.99 Thousand | 2.37 Million | 184.8 Thousand |
Selling, General and Administrative Expenses | 855 Thousand | 553 Thousand | 2.37 Million | 184.8 Thousand |
Research and Development Expenses | - | - | - | - |
Other Expenses | - | - | - | - |
Cost and Expenses | 855 Thousand | 552.99 Thousand | 2.37 Million | 184.8 Thousand |
Operating Income | -4.31 Million | -7.7 Million | 2.66 Million | -184.8 Thousand |
Interest Expense | - | - | - | - |
Income Tax Expense | - | 565 Thousand | 622 Thousand | -262.27 Thousand |
Earnings before Tax | -4.18 Million | -7.25 Million | 2.67 Million | -266.4 Thousand |
Net Income | -4.18 Million | -6.68 Million | 2.05 Million | -266.4 Thousand |
Earnings Per Share Basic | -0.39 | -0.48 | 0.18 | - |
Earnings Per Share Diluted | -0.39 | -0.48 | 0.18 | - |
Weighted Average Shares Outstanding | 10.6 Million | 13.92 Million | 11.41 Million | - |
Weighted Average Shares Outstanding (Diluted) | 10.6 Million | 13.92 Million | 11.25 Million | - |
Gross Margin | 1.00 | 1.00 | 1.00 | - |
EBIT Margin | - | 1.07 | 0.53 | - |
Profit Margin | 1.21 | 0.94 | 0.41 | - |
EBITDA | - | -7.68 Million | 2.67 Million | -81.6 Thousand |
Earnings Before Tax Margin | 1.25 | 1.08 | 0.53 | - |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | -1.09 Million | -1.09 Million | -1.3 Million | -3.45 Million | -1.3 Million | -421.5 Thousand |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | -1.09 Million | -1.09 Million | -1.3 Million | -3.45 Million | -1.3 Million | -421.5 Thousand |
Operating Expenses | -2.36 Million | -2.36 Million | -1.96 Million | 855 Thousand | 194.99 Thousand | 232.49 Thousand |
Selling, General and Administrative Expenses | 188.5 Thousand | 188.5 Thousand | 195 Thousand | - | 195 Thousand | 232.5 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | -2.55 Million | -2.55 Million | -2.15 Million | - | - | - |
Cost and Expenses | -2.36 Million | -2.36 Million | -1.96 Million | 855 Thousand | 194.99 Thousand | 232.49 Thousand |
Operating Income | 1.27 Million | 1.27 Million | 654 Thousand | -4.31 Million | -1.5 Million | -654 Thousand |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | -2.55 Million | -2.55 Million | 40.5 Thousand | 126 Thousand | - | - |
Earnings before Tax | -1.24 Million | -1.24 Million | -1.46 Million | -4.18 Million | -1.46 Million | -631.5 Thousand |
Net Income | -1.24 Million | -1.24 Million | -1.46 Million | -4.18 Million | -1.46 Million | -631.5 Thousand |
Earnings Per Share Basic | -0.12 | -0.12 | -0.17 | - | -0.17 | -0.05 |
Earnings Per Share Diluted | -0.12 | -0.12 | -0.17 | - | -0.17 | -0.05 |
Weighted Average Shares Outstanding | 10.79 Million | 10.79 Million | 8.57 Million | 10.6 Million | 8.57 Million | 12.63 Million |
Weighted Average Shares Outstanding (Diluted) | 10.79 Million | 10.79 Million | 8.57 Million | 10.6 Million | 8.57 Million | 12.63 Million |
Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
EBIT Margin | 1.17 | 1.17 | -0.03 | - | 1.15 | 1.54 |
Profit Margin | 1.14 | 1.14 | 1.12 | 1.21 | 1.12 | 1.50 |
EBITDA | -1.27 Million | -1.27 Million | 40.5 Thousand | - | -1.49 Million | -649 Thousand |
Earnings Before Tax Margin | -1.17 | -1.17 | -0.50 | 1.25 | 1.15 | 1.55 |
LIPPISYS
FBDS
024890
LAHOTIOV
300037
GVOLT